NCT00891163

Evaluate the Depth and Duration of Anesthesia

A Randomized, Double-Blind, Two-Period, Crossover Study to Evaluate the Depth and Duration of Anesthesia of Synera™ Patches Compared to Placebo Patches Applied to Healthy Adult Volunteers

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 25 (actual)
• Sponsor: ZARS Pharma Inc. · Industry
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Accepted

Summary

The purpose of the study is to determine the depth (mm) of anesthesia provided by the Synera topical patch (using sensory depth and pain depth evaluations), and to determine the duration (minutes) of anesthesia provided by the Synera topical patch (using dermal sensory testing and thermal sensory testing evaluations), compared with a matching heated placebo patch.

Conditions

• Pain

Interventions

Type	Name	Description
DRUG	Synera™ Topical Patch (70 mg lidocaine/70 mg tetracaine)	30 minute applicable on antecubital fossa
DRUG	Placebo Patch	placebo

Timeline

• Start date: 2006-12-01
• Primary completion: 2007-04-01
• Completion: 2007-04-01
• First posted: 2009-05-01
• Last updated: 2009-05-01

Locations

1 site across 1 country: United States